{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-087888","form_type":"8-K","ticker":"INKT","cik":"0001840229","company_name":"MiNK Therapeutics, Inc.","filed_at":"2025-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.062939+00:00","generated_at":"2026-05-19T03:23:00.165560+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"MiNK Therapeutics stockholders elect directors, approve option exchange, ratify KPMG at 2025 annual meeting","bullets":["Jennifer Buell and Ulf Wiinberg elected as Class I directors with 2,337,073 and 2,312,077 votes For, respectively.","Option exchange proposal approved: 2,269,364 For, 97,538 Against, 1,317 Abstain, 424,803 broker non-votes.","Ratification of KPMG LLP as auditor for FY2025: 2,773,188 For, 12,846 Against, 6,988 Abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-087888","json":"https://secwatch.observer/filing/0000950170-25-087888.json","markdown":"https://secwatch.observer/filing/0000950170-25-087888.md","text":"https://secwatch.observer/filing/0000950170-25-087888.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840229/000095017025087888/0000950170-25-087888-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840229/000095017025087888/inkt-20250618.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T03:23:00.165560+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}